https://www.selleckchem.com/pr....oducts/Estradiol.htm
01). Interviews revealed different motivations for enteral feeding, including perceived quality of life benefits. We provide Class II evidence that enteral feeding prolongs the akinetic-mute phase of all aetiological types of prion disease. These data may help support decision making in palliative care. Enteral feeding is an important potential confounder in prion disease clinical trials that use survival as an endpoint.Variants in MCM3AP, encoding the germinal-centre associated nuclear protein, have been associated with progressive p
Like
Comment
Share
